Bavarian Nordic — August 2021

Helge_LarsenPI-redaktør

Opdatering på Proinvestors 30 facebookgrupper: https://www.proinvestor.com/index.php?p=debat_1&postid=95916

exitnu

Zealand Pharma regnskab om 5. min.

SEACOP

ZEAL: https://view.news.eu.nasdaq.com/view?id=b3ca244e2ceb0c501c6e00b5ee5384420&lang=en

exitnu

Zealand Pharma Interim report for H1 2021

Zealand Pharma Launches ZEGALOGUE (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas
Company annoucement - No. 50 / 2021

Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas

Company annoucement - No. 50 / 2021 Interim report for H1 2021 Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline...

GlobeNewswire News Room (www.globenewswire.com)

Messersmith

Kan se at saxo bruger vp. Og dermed ikke kan shorte privat aktier uden tilladelse 3.1 Registrering i VP
I VP registreres udstedelse og omsætning af
danske obligationer, danske aktier og andre
værdipapirer, der er godkendt til registrering af
Finanstilsynet samt rettigheder over disse. Regi-
streringen sker på en VP-konto, som Saxo Pri-
vatbank opretter til dig med Saxo Privatbank
som kontoførende institut. https://www.google.com/url?sa=t&source=web&rct=j&url=http://www.privatbank.saxo/Doc

exitnu

Financial results for the first half of 2021

Revenue: DKK 132.1 million / USD 21.1 million (DKK 233.4 million / USD 35.1 million in the first six months of 2020).

deleted-user

@Pensionisten har du slået dig?

exitnu

Net operating expenses: DKK -616.6 million / USD -98.5 million (DKK -437.2 million / USD -65.7 million in the first six months of 2020).

exitnu

Net operating result: DKK -550.8 million / USD -88.0 million (DKK -230.9 million / USD -34.7 million in the first six months of 2020).

exitnu

Cash, cash equivalents, and marketable securities: DKK 1,282.9 million / USD 205.0 million as of June 30, 2021 (June 30, 2020: DKK 1,665.0 million / USD 250.2 million).

exitnu

Bullseye i

exitnu

"... with multiple clinical milestones on the horizon in the second half of the year, we are well positioned to achieve our goal of offering five marketed products by 2025."

Svingtraderen

Tak - synes ikke folk betaler den op:(

deleted-user

Salget steg med næsten 25 % i Q2.... Hvis det bare forstætter de næste mange år De er på rette vej og man ko skal starte et sted. Bliver interessent at høre news om omsætning på nødpennen, når ledelsen er klar